Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from Abingdon Health PLC ( (GB:ABDX) ) is now available.
Abingdon Health PLC reported a 28.4% revenue growth for the first half of 2025, driven by strategic acquisitions, expansion into new markets, and increased contract service activities. The company is optimistic about continued growth, with significant contracts secured and new facilities opening, including a US site in Madison, Wisconsin. The company aims to achieve cash-flow positivity by 2026 without additional funding, supported by a robust pipeline of projects and a strengthened service offering.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider based in York, England, with facilities in the UK and the USA. The company specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services, catering to sectors such as infectious disease, clinical testing, animal health, and environmental testing. Abingdon Health also offers a range of self-tests through its e-commerce platform and provides regulatory services to the in vitro diagnostic and medical device industries.
YTD Price Performance: -6.45%
Average Trading Volume: 115,903
Technical Sentiment Signal: Buy
Current Market Cap: £14.04M
Find detailed analytics on ABDX stock on TipRanks’ Stock Analysis page.